Sr Director, ToxicologyAvidity BiosciencesSan Diego, California, United States
Hitching a Ride to Transduce Barriers: Nonclinical Safety Considerations for Developing Transcriptome Modulating Therapies (S08)
Tuesday, November 19, 20249:00 AM – 12:00 PM CT